This work is licensed under the Creative Commons Attribution 4.0 International License.
Bernstein JA, Moellman J. Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema. Int J Emerg Med. 2012;5:39.BernsteinJAMoellmanJEmerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema201253910.1186/1865-1380-5-39Search in Google Scholar
Bernstein JA, Cremonesi P, Hoffmann TK, Hollingsworth J.: Angioedema in the emergency department: a practical guide to differential diagnosis and management, Int J Emerg Med. 2017;10:15.BernsteinJACremonesiPHoffmannTKHollingsworthJAngioedema in the emergency department: a practical guide to differential diagnosis and management2017101510.1186/s12245-017-0141-zSearch in Google Scholar
Lombardi C, Crivellaro M, Dama A, Senna G, Gargioni S, Passalacqua G. Are physicians aware of the side effects of angiotensin-converting enzyme inhibitors?: a questionnaire survey in different medical categories. Chest. 2005;128:976–9.LombardiCCrivellaroMDamaASennaGGargioniSPassalacquaGAre physicians aware of the side effects of angiotensin-converting enzyme inhibitors?: a questionnaire survey in different medical categories2005128976910.1378/chest.128.2.976Search in Google Scholar
Cicardi M, Zanichelli A. Acquired angioedema. Allergy Asthma Clin Immunol. 2010;6:14.CicardiMZanichelliAAcquired angioedema201061410.1186/1710-1492-6-14Search in Google Scholar
Wu MA, Castelli R. The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity. Clin Chem Lab Med. 2016;54:207-14.WuMACastelliRThe Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity2016542071410.1515/cclm-2015-0195Search in Google Scholar
Otani IM, Banerji A. Acquired C1-inhibitor deficiency, Immunol Allergy Clin North Am. 2017; 37:497-511.OtaniIMBanerjiAAcquired C1-inhibitor deficiency20173749751110.1016/j.iac.2017.03.002Search in Google Scholar
Bouillet-Claveyrolas L, Ponard D, Drouet C, Massot C. Clinical and biological distinctions between type I and type II acquired angioedema. Am J Med. 2003;115:420–1.Bouillet-ClaveyrolasLPonardDDrouetCMassotCClinical and biological distinctions between type I and type II acquired angioedema2003115420110.1016/S0002-9343(03)00396-6Search in Google Scholar
Dobson G, Edgar D, Trinder J. Angioedema of the tongue due to acquired C1 esterase inhibitor deficiency. Anaesth Intensive Care. 2003;31:99–102.DobsonGEdgarDTrinderJAngioedema of the tongue due to acquired C1 esterase inhibitor deficiency2003319910210.1177/0310057X030310012012635405Search in Google Scholar
Cicardi M, Zanichelli A. The acquired deficiency of C1-inhibitor: lymphoproliferation and angioedema. Curr Mol Med. 2010;10:354–60.CicardiMZanichelliAThe acquired deficiency of C1-inhibitor: lymphoproliferation and angioedema2010103546010.2174/15665241079131706620455857Search in Google Scholar
Cicardi M. Acquired C1 inhibitor deficiency: clinical manifestations, epidemiology, pathogenesis, and diagnosis - UpToDate. Available at: https://www.uptodate.com/contents/acquired-c1-inhibitor-deficiency-clinical-manifestationsepidemiology-pathogenesis-and-diagnosis?source5search_result&search5acquiredangioedema&selectedTitle51w32 Accessed: 4th December, 2016.CicardiMAvailable athttps://www.uptodate.com/contents/acquired-c1-inhibitor-deficiency-clinical-manifestationsepidemiology-pathogenesis-and-diagnosis?source5search_result&search5acquiredangioedema&selectedTitle51w32Accessed: 4th December2016Search in Google Scholar
Farkas H, Veszeli N, Kajdácsi E, Cervenak L, Varga L. “Nuts and bolts” of laboratory evaluation of angioedema. Clin Rev Allergy Immunol. 2016;51:140–51.FarkasHVeszeliNKajdácsiECervenakLVargaL“Nuts and bolts” of laboratory evaluation of angioedema2016511405110.1007/s12016-016-8539-627142368Search in Google Scholar
Lam DH, Levy NB, Nickerson JM, Gruenberg DA, Lansigan F. Acquired angioedema and marginal zone lymphoma. J Clin Oncol. 2012;30:e151–3.LamDHLevyNBNickersonJMGruenbergDALansiganFAcquired angioedema and marginal zone lymphoma201230e151310.1200/JCO.2011.38.995722508826Search in Google Scholar
Branellec A, Bouillet L, Javaud N et al. Acquired C1-inhibitor deficiency: 7 patients treated with rituximab. J Clin Immunol. 2012;32:936–41.BranellecABouilletLJavaudNet alAcquired C1-inhibitor deficiency: 7 patients treated with rituximab2012329364110.1007/s10875-012-9691-222526593Search in Google Scholar